About
Investor and Media Contacts:
ir@clearsidebio.com
(678) 430-8206
Source:
![](https://ml.globenewswire.com/media/NWM3ODI1ZWItMjZiNS00YzMyLWJlNjktMzFkYjMwNzRmYTAwLTEwMjI3MzU=/tiny/Clearside-Biomedical-Inc-.png)
2023 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +2.68% |
|
-6.50% | -1.71% |
13/05 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
09/05 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
About
Investor and Media Contacts:
ir@clearsidebio.com
(678) 430-8206
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-1.71% | 85.94M | |
+15.85% | 122B | |
+18.91% | 113B | |
+7.48% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.01% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |